OQROSign up free
Insider trade

Exozymes (EXOZ): Chief Commercial Officer received 8,887 shares

Damien Alan Perriman, Chief Commercial Officer at Exozymes, reported a grant / award of 8,887 shares.

8,887
Shares · @ $8.44
Traded
Apr 1, 2026
Filed
Apr 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Apr 8, 2026InsiderOfficer sold ~$7.5K of EXOZ shares in the open market
    2. Apr 9, 2026InsiderOfficer sold ~$7.9K of EXOZ shares in the open market
    3. Jun 5, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
    4. Jun 17, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
    5. Jun 30, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Exozymes

    For Exozymes, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EXOZ page.

    Other recent filings by Damien Alan Perriman, Chief Commercial Officer

    The full history of Damien Alan Perriman, Chief Commercial Officer is on the profile page.

    How this filing works

    Explore the data

    Other disclosures at Exozymes

    Everything OQRO holds on this company is on its EXOZ page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    Sign up freeAlready have an account? Log in

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data